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Transfusion-related acute lung injury in  
multiple traumatized patients 
 
 
 
Abstract 
Background: Many of the multiple traumatized patients who refer to the hospital need 
transfusion. Transfusion-related acute lung injury (TRALI) is a serious clinical syndrome 
associated with the transfusion of plasma-containing blood components. In the article, we 
present a case of TRALI following transfusion of packed red blood cells  
Case Presentation: A 24 year old male referred to Shahid Beheshti Hospital due to 
multiple trauma with left femoral and humerus fractures. Due to severe anemia he received 
3 units of packed red blood cells. The symptoms of TRALI began 2 hours after 
transfusion. He was transferred to intensive care unit (ICU) due to metabolic acidosis and 
severe hypoxia. The TRALI was confirmed after ruling out the other probable pulmonary 
diseases. He recovered and was discharged. 
Conclusion: Transfusion related acute lung injury should be considered in any case 
receiving transfusion of plasma containing blood components.  
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Many of the patients admitted to the hospital due to multiple trauma need 
transfusion. Allogeneic blood transfusion can be viewed as a form of temporary 
transplantation. Transfusion introduces a multitude of foreign antigens and living cells into 
the recipient that will persist for a variable time
 
(1).  Transfusion-related acute lung injury 
(TRALI) is a serious blood transfusion complication. TRALI was first reported in the 
1950’s with the initial case series in 1966 and its fatality was reported to the U.S. Food and 
Drug Administration Center for Biological Evaluation and Research in 1992
 
(2-5). TRALI 
is defined as an acute onset of bilateral infiltrates and hypoxemia in the absence of 
increased left arterial pressure. It is the leading cause of transfusion-related fatalities and 
occurs approximately one in every 5000 transfusions with mortality of 6-9%
 
(6-8).  
Although TRALI is typically associated with plasma components such as platelets and 
fresh frozen plasma, some cases have been reported with packed red blood cells (PRBC) 
since there was some residual plasma in it
 
(9). It seems that certain patient groups may be 
significantly at higher risk
 
(10). In this study was present a case of transfusion- related 
acute lung injury following transfusion of packed red blood cells. 
 
Case presentation 
A 24 year-old male multiple traumatized patient with left femur and humerus 
fractures suffered from severe respiratory compromise several hours after packed red 
blood cell transfusion. The symptoms typically began 2 hours after packed red blood cell 
(PRBC) transfusion in the ward and fully manifested within 6 hours of the second packed 
red blood cell (PRBC) transfusion in the intensive care unit (ICU).  
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There was not any positive finding in his past medical 
history, review of systems and family history. The patient’s 
vital signs were stable accompanied with tachypnea, 
tachycardia and mild fever (HR: 130/min, RR: 32 beats/min, 
T: 38.2ºC) after first PRBC transfusion. The patient was 
transferred to the ICU with probable diagnosis of pulmonary 
emboli. In the ICU, he received second PRBC due to his 
anemia (Hb: 7.4 mg/dl).  
His vital signs became worse and unstable and the serial 
arterial blood gas of our patient showed metabolic acidosis 
accompanied with severe hypoxia (PH: 7.26, PCO2:28, 
HCO3:14, PO2:68, PaO2:72-78%, Na: 145, K: 4.8, Hb: 7.2 
mg/dl). He had a marked respiratory reaction, associated 
with bilateral pulmonary infiltrates in the chest x-ray. 
Radiographs were patchy in the first hours following 
transfusion with progression of the alveolar and interstitial 
infiltrates, such that there was a ‘whiteout’ of the entire lung 
(figure 1).  
 
 
 
 
 
 
 
 
 
 
 
Figure 1. 6 hours after transfusion 
 
Orotracheal intubation after a deep sedation was done. 
We prescribed ventilator support according to lung 
protection strategies (Mode: ACMV, Vt: 4-5 ml/kg, RR: 25-
28 cycle/min, PEEP: 14-18 CmH2o, I/E:1/1.2, FiO2:100%) 
accompanied with muscle relaxant and propofol infusion for 
72 hours. Central venous line from internal jugular vein 
prepared for the patient and its pressure was measured 
(CVP 12 CmH2O). In ECHO, there was no evidence of 
fluid overload or heart failure. The diagnosis of TRALI is 
based primarily upon clinical signs and symptoms, not 
laboratory findings and there is no single test for this 
condition
 
(11). Although, in this patient radiological findings 
tend to be even more remarkable than physical findings 
(figure 2). We confirmed transfusion-related acute lung 
injury by excluding other probable diagnoses in our checklist 
like, pulmonary emboli, pneumonia, congestive heart failure, 
myocardial infarction, aspiration pneumonia and renal failure 
and sepsis. 
After recovery from TRALI, the patient was prepared for 
orthopedic surgery. Transfusion could not be avoided during 
the operation. In spite of the recommendations, (PRBC) was 
transfused to the patient, and then he showed the evidence of 
TRALI and was admitted to the ICU again. Although our 
patient was discharged from the hospital without any 
permanent sequelae, we considered a cumulative effect in the 
pathogenesis of TRALI.  
 
 
 
 
 
 
 
 
 
 
 
Figure 2. 48 hours after treatment 
 
 
Discussion 
TRALI is an adverse life-threatening event of 
transfusion, which has an increasing incidence, even though 
it is probably underdiagnosed and underreported
 
(10, 12, 13). 
A sudden onset of respiratory distress within 6 hours of 
transfusion requires that two important noninfectious 
complications of blood transfusion be evaluated. These two 
conditions are circulatory overload from rapid or massive 
transfusion and an immune-mediated acute lung injury 
resulting from transfusion of plasma-containing products
 
 
(14, 15). Although, some studies have investigated lower 
acceptable limits for transfusion triggers, as RBC transfusion 
does not consistently improve tissue oxygen consumption in 
critically ill patients and there are no clear evidence-based 
guidelines on the lower limits of acceptable hemoglobin or 
hematocrit levels,
 
especially in multiple traumatized patients 
or perioperative period, because of potential risk of TRALI 
in this high risk group, lower transfusion targets are being 
advocated (16, 17). 
Treatment in TRALI is supportive and conservative. 
More than 70% of patients will require mechanical 
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ventilation because of the development of frothy secretions 
or diffuse alveolar hemorrhage, hypoxemia, and the 
observation of diffuse bilateral infiltrates on portable chest x-
ray film. In about 80% of the affected patients; like our 
patient, pulmonary infiltrates appear at the time of the 
reaction and will be resolved within 96 hours. Diuretic is not 
indicated and the role of steroids is unproven (14, 18). 
TRALI presentation after packed red blood cell 
transfusion is a rare event because it is typically associated 
with plasma components such as fresh frozen plasma. 
TRALI is indeed PMN-mediated and has similar pulmonary 
findings to acute lung injury and acute respiratory distress 
syndrome. The pathogenesis of TRALI is not completely 
understood. Leukocyte antibodies in donor plasma have been 
implicated in most cases with antibodies directed at human 
leukocyte antigen (HLA) class I, HLA class II or neutrophil-
specific antigens, particularly HNA-3a; in addition, 
activation of pulmonary endothelium is important in the 
development of TRALI. A two-hit hypothesis has been 
suggested wherein the pre-existing pulmonary pathology (the 
first-hit) leads to the localization of neutrophils to the 
pulmonary microvasculature
 
(13, 14). The second hit occurs 
when the aforementioned antibodies are transfused and 
attached and the activated neutrophils lead to the release of 
cytokines and vasoactive substances that induce non-cardiac 
pulmonary edema
 
(14, 19).  
In this case, trauma was the first hit as a precipitating 
factor and we consider transfusion as second hit. This 
challenging unusual presentation of TRALI in a multiple 
traumatized patient after packed red blood cell transfusion 
and recurrence in clinical features after transfusion during 
surgery accompanied with difficulty in diagnosis 
confirmation, intensive care management and patients' 
ventilation support represented valid work and there were 
few publications or presentations in this field. 
Susceptibility to suffering from TRALI in specific 
patients is predictable (10, 20). Prospective studies are 
required to properly identify patients who are at risk for 
developing TRALI. In conclusion, transfusion related acute 
lung injury should be considered in any case receiving 
transfusion of plasma containing blood components 
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